Vera Therapeutics, Inc.
VERADrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 1 past
How VERA's past catalysts played out
Polycythemia Vera
2 drugs in this indication
BK Virus Infection
1 drug in this indication
IgA Nephropathy (IgAN)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Vera Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Vera Therapeutics, Inc.'s (VERA) pipeline across Phase 3, Phase 2. Its lead program is Atacicept (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Vera Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Vera Therapeutics, Inc. (VERA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track VERA biotech catalysts?→
Add VERA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Vera Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.